Replies to post #44 on TC BioPharm Holdings Plc (TCBP)

[Cameo Brien]

(NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, today highlighted their intellectual property

[resx18]

Phase 2 trials $TCBP